Comparing the current results to its competitors, Ashland Inc reported Revenue increase in the 3 quarter 2026 by 7.34 % year on year. The sales growth was above Ashland Inc 's competitors' average revenue growth of 1.73 %, achieved in the same quarter.
Ashland Inc 's Comment on Competition and Industry Peers
Ashland operates in the fragmented additives and specialty ingredients industries, offering a wide range of product lines tailored to specific customer needs. Competition occurs at global, regional, and local levels and is based on factors such as product performance and quality, price, availability and security of supply, responsiveness in product development, customer service, industry knowledge, and technical capability. Some competitors are significantly larger and possess greater financial resources, providing them with increased operational and financial flexibility. The industry is increasingly global, with companies seeking leadership positions beyond their domestic markets. Many product lines face competition both domestically and internationally due to industry consolidation, pricing pressures, and alternative technologies. Ashland utilizes its brand and global scale to combine operational agility with focused investment in targeted areas to differentiate its products and technologies. The company owns valuable trademarks and holds licensed intellectual property rights from third parties.
With revenue growth of 7.34 % within Overall company, Ashland Inc achieved improvement in market share, within Overall company to approximately 1.57 %. << More on ASH Market Share.
*Market share is calculated based on total revenue.
May 5, 2025
Ashland Inc. Navigates Executive Transitions and Strategic Growth Amid Technological Innovations In a notable shift within its executive framework, Ashland Inc. (NYSE: ASH) announced that Kevin Willis, the esteemed senior vice president and chief financial officer, will be departing the company to explore new professional opportunities. His final day with Ashland is set for May 16, 2025. This transition at the executive level comes at a pivotal time as the company gears up for its anticipated strategy update event for analysts and investors, scheduled for December 10, 2024, in New York City.The upcoming strategy update is expected to provide a comprehensive analysis of Ashland’s strategic priorities, key ...
June 24, 2024
by In a series of recent developments, Ashland Inc. (NYSE: ASH), a global leader in specialty chemicals, has taken significant steps to reinforce its strategic direction, augment leadership capabilities, and streamline its portfolio. These moves demonstrate Ashland s commitment to propelling growth, driving innovation, and maximizing value for its stakeholders.Ashland s latest addition to its leadership team comes in the form of Omar Irani, who has been appointed as the Vice President of Strategy, Mergers and Acquisitions, and Portfolio Management, effective July 22, 2024. Reporting to Guillermo Novo, the Chair and CEO of Ashland, Irani s expertise will be instrumental in charting a course for future growth,...
June 4, 2024
In a strategic move towards revitalizing its Life Sciences business, global specialty chemicals company Ashland Inc. recently announced the appointment of Alessandra Faccin as the new senior vice president and general manager. With her wealth of experience and expertise, Faccin is expected to spearhead the company s growth in the Life Sciences sector, bringing a fresh perspective and innovative strategies to the table.Faccin will be reporting directly to Guillermo Novo, the esteemed chair and chief executive officer of Ashland. Her role will encompass overseeing all operations related to the Life Sciences segment, as well as implementing strategic initiatives to enhance the company s performance in this high...
May 8, 2024
Ashland Inc., a prominent global chemical company, has announced the appointment of Ashish K. Kulkarni as a new member of its Board of Directors. Kulkarni, the CEO of Kebotix, a startup focused on commercializing artificial intelligence methods for new material commercialization, brings a wealth of experience from his previous leadership positions at GAF, Avantor, and Celanese Corporation. This strategic addition to Ashland s board comes at a time when the company faces a revenue decrease in Q3 2023, but remains more resilient than its competitors. Appointment of Ashish K. Kulkarni to Ashland s Board of DirectorsAshland Inc. has welcomed Ashish K. Kulkarni as a new member of its Board of Directors. With his ...
May 7, 2024
Ashland Inc. (NYSE: ASH) has recently announced its decision to offload its nutraceuticals business to Turnspire Capital Partners LLC (Turnspire). The transaction is expected to be finalized in the third quarter of 2024, subject to customary closing conditions. This move comes as Ashland strives to adapt to market challenges and optimize its overall business performance. Furthermore, in light of the revenue decrease in the third quarter of 2023, Ashland has been closely monitoring competition and market share performance to enhance its position in the industry.Ashland Inc. witnessed a revenue decrease of -18.07% in the third quarter of 2023 compared to the prior year. Although this decline was slower than th...
April 15, 2024
Ashland Inc. Appoints Scott A. Tozier as New Director Amidst Revenue DecreaseAshland Inc., a global chemical company, recently announced the appointment of Scott A. Tozier as its new director. Tozier, a strategic advisor to the CEO and former executive vice president and chief financial officer of Albemarle Corporation, brings a wealth of experience and expertise to his new role. This decision comes at a crucial time for Ashland Inc., as the company faces a decline in revenue and market share.In the third quarter of 2023, Ashland Inc. reported a year-on-year revenue decrease of 18.07%. While this decline is significant, it is important to note that it is slower than the combined decrease of its competitors, ...
Celanese Corporation operates as a global leader in specialty materials and chemicals, providing a diverse array of innovative products and solutions tailored for various industries. Its business model emphasizes collaboration and advanced technology development, focusing on enhancing performance and sustainability for customers while leveraging its extensive global presence to deliver value-added solutions.
Huntsman Corporation operates as a global manufacturer and marketer of differentiated chemicals. The company focuses on producing and selling a wide range of chemical products across various industries, including chemicals for plastics, coatings, textiles, detergents, and automotive markets. Huntsman's business model aims to meet customer needs through innovation, efficiency, and global distribution channels.
Hawkins Inc operates as a specialty chemical company, providing solutions to a wide array of industries. Their business model revolves around sourcing, manufacturing, and distributing chemicals, as well as offering expert technical expertise and support to their customers. By delivering tailored chemical solutions and fostering long-term relationships, Hawkins aims to meet the unique needs of various sectors, including industrial, pharmaceutical, and personal care.
Sources:
Ashland Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ashland Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
